A new role for microRNAs, as ligands of Toll-like receptors

被引:116
|
作者
Fabbri, Muller [1 ]
Paone, Alessio [2 ]
Calore, Federica [2 ]
Galli, Roberta [2 ]
Croce, Carlo M. [2 ]
机构
[1] Univ So Calif, Keck Sch Med, Dept Pediat & Mol Microbiol & Immunol,Childrens H, Norris Comprehens Canc Ctr,Childrens Ctr Canc & B, Los Angeles, CA 90033 USA
[2] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA
关键词
microRNAs; Toll-like receptors; tumor microenvironment; IL-6; TNF-alpha; metastasis; exosomes; IMMUNE-RESPONSE MODIFIERS; NF-KAPPA-B; CYTOKINE PRODUCTION; EXOSOME RELEASE; DENDRITIC CELLS; TUMOR-GROWTH; LUNG-CANCER; INFLAMMATION; MECHANISM; INDUCTION;
D O I
10.4161/rna.23144
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor microenvironment plays a central role in the development and dissemination of cancer cells. In addition to studying each specific cellular component of the microenvironment it has become clear that it is the type and amount of information that cells exchange that ultimately affects cancer phenotype. Recently, it has been discovered that intercellular communication occurs through the release of microvesicles and exosomes, whose cargo represents the information released by one cell to a recipient cell. A key component of this cargo is represented by microRNAs (miRNAs), small non-coding RNAs with gene regulatory functions. We discovered that miRNAs released by cancer cells within microvesicles can reach and bind to Toll-like receptors (TLRs) in surrounding immune cells, and activate them in a paracrine loop. As a result, immune cells produce cytokines that increase cell proliferation and metastatic potential. This discovery provides the rationale for the development of new drugs that might be used in the treatment of cancer as well as other inflammation-related diseases.
引用
收藏
页码:169 / 174
页数:6
相关论文
共 50 条
  • [21] The Role of Toll-like Receptors in Esophageal Cancer
    Davakis, Spyridon
    Kapelouzou, Alkistis
    Liakakos, Theodoros
    Mpoura, Maria
    Stergiou, Dimitrios
    Sakellariou, Stratigoula
    Charalabopoulos, Alexandros
    ANTICANCER RESEARCH, 2022, 42 (06) : 2813 - 2818
  • [22] Toll-like receptors and their role in gastrointestinal disease
    Testro, Adam G.
    Visvanathan, Kumar
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (06) : 943 - 954
  • [23] A Clear and Present Danger: Endogenous Ligands of Toll-like Receptors
    Sloane, Jacob A.
    Blitz, Daina
    Margolin, Zachary
    Vartanian, Timothy
    NEUROMOLECULAR MEDICINE, 2010, 12 (02) : 149 - 163
  • [24] Mycoplasma lipoproteins and Toll-like receptors
    Zuo, Ling-ling
    Wu, Yi-mou
    You, Xiao-xing
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2009, 10 (01): : 67 - 76
  • [25] The Role of Toll-Like Receptors in Oncotherapy
    Liu, Caiqi
    Han, Ci
    Liu, Jinfeng
    ONCOLOGY RESEARCH, 2019, 27 (08) : 965 - 978
  • [26] Toll-Like Receptors and Renal Disease
    Robson, Michael G.
    NEPHRON EXPERIMENTAL NEPHROLOGY, 2009, 113 (01): : E1 - E7
  • [27] Lung cancer and Toll-like receptors
    Aldo Pinto
    Silvana Morello
    Rosalinda Sorrentino
    Cancer Immunology, Immunotherapy, 2011, 60 : 1211 - 1220
  • [28] Activation of mammalian Toll-like receptors by endogenous agonists
    Johnson, GB
    Brunn, GJ
    Platt, JL
    CRITICAL REVIEWS IN IMMUNOLOGY, 2003, 23 (1-2) : 15 - 44
  • [29] Lung cancer and Toll-like receptors
    Pinto, Aldo
    Morello, Silvana
    Sorrentino, Rosalinda
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (09) : 1211 - 1220
  • [30] Platelet toll-like receptors in thromboinflammation
    Paola D'Atri, Lina
    Schattner, Mirta
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2017, 22 : 1867 - 1883